Transcultural Validation in French of the Systemic Lupus Activity Questionnaire (SLAQ) and the Lupus Quality Of Life (LupusQoL) Questionnaire
NCT02857452 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 162
Last updated 2016-08-05
Summary
The evaluation of lupus patients must include several approaches, in particular disease activity and quality of life.
The Systemic Lupus Activity Questionnaire (SLAQ) is a validated self-questionnaire to evaluate disease activity. It has the advantage of being inexpensive, easy to use in large cohorts and has been used in several studies. It has never been validated in French. The Lupus Quality Of Life (LupusQoL) is a self-questionnaire to evaluate quality of life and is specific to systemic lupus erythematous; it was developed from interviews with patients.
This tool, validated in a British population, has never been validated in French.
Conditions
Interventions
- OTHER
-
SLA Questionnaire
- OTHER
-
Lupus Qol Questionnaire
Sponsors & Collaborators
-
Centre Hospitalier Universitaire Dijon
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-01-31
- Primary Completion
- 2010-02-28
Countries
- France
Study Locations
More Related Trials
-
Validation of the Lupus Low Disease Activity State (LLDAS) in the Asia Pacific Region
NCT03138941 ·Status: RECRUITING
-
Description of Compliance With Hydroxychloroquine Treatment in Patients With Systemic Lupus Erythematosus
NCT06161363 ·Status: COMPLETED
-
Characterizing Adherence to Treatment and Satisfaction With Care in Patients With Cutaneous Lupus
NCT06506214 ·Status: COMPLETED
-
Comparison of the Clinical Examination and the Joint Ultrasonography in Lupus Patients
NCT02922114 ·Status: COMPLETED ·Phase: NA
-
Multicomponent Strategy to Implement a Clinical Practice Guideline and Improve Health Outcomes in People With SLE
NCT03537638 ·Status: COMPLETED ·Phase: NA
-
Health-related Quality of Life Measure in Pediatric Lupus
NCT00280137 ·Status: COMPLETED
-
Utilizing Qualitative and Quantitative Methods to Understand a New Model of Type 1 and 2 Systemic Lupus Erythematosus (SLE)
NCT05426902 ·Status: COMPLETED ·Phase: NA
-
Lupus Education Alliance Program
NCT05243875 ·Status: TERMINATED ·Phase: NA
-
Systemic Lupus Erythematosus Exercise Program
NCT03942718 ·Status: COMPLETED ·Phase: NA
-
Activity and Nutrition Trial in Lupus to Energize and Renew
NCT02281513 ·Status: COMPLETED ·Phase: NA
-
Systemic Lupus Erythematosus Within the Framework of the Multidisciplinary Consultation
NCT04320680 ·Status: RECRUITING ·Phase: NA
-
Validation of a Mobile Phone Based on EPRO Tool in Subjects With Systemic Lupus Erythematosus
NCT03142711 ·Status: COMPLETED
-
Dissemination of the Lupus Interactive Navigator
NCT02950714 ·Status: COMPLETED ·Phase: NA
-
Care Coordination Approaches to Learning Lupus Self-management
NCT04400240 ·Status: COMPLETED ·Phase: NA
-
Comparison of Clinical and Serological Differences Among Juvenile, Adult, and Late-onset Systemic Lupus Erythematosus
NCT05724940 ·Status: UNKNOWN
-
Disease Progression and Activity in Patients With Systemic Lupus Erythematosus
NCT00339261 ·Status: COMPLETED
-
Systemic Lupus Erythematosus
NCT05984316 ·Status: RECRUITING ·Phase: NA
-
A Study of Laquinimod in Participants With Systemic Lupus Erythematosus (SLE) Active Lupus Arthritis
NCT01085084 ·Status: COMPLETED ·Phase: PHASE2
-
The Impact of Illness Perceptions on Health Related Outcomes in Patients With Lupus and Systemic Sclerosis
NCT02655640 ·Status: COMPLETED
-
Immune Response to SARS-CoV-2 Vaccination in Systemic Lupus
NCT04894253 ·Status: TERMINATED
-
Lupus Intervention for Fatigue Trial
NCT02653287 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Auto-immune Diseases and Quality of Life
NCT02855840 ·Status: COMPLETED
-
Improving the Assessment of SLE Disease Activity
NCT03144063 ·Status: COMPLETED
-
Covid-19 in Lupus Patients
NCT04355702 ·Status: COMPLETED
-
PRediction Of Flares In Lupus With autoantibodiEs and Chemokines
NCT04951427 ·Status: UNKNOWN